They divided the participants into cognitively normal, stable mild cognitive impairment, progressive MCI, and Alzheimer’s dementia and they found that YKL-40 levels can be a predictor of AD diagnosis and are associated with hippocampal atrophy. This evidence concerns the gene CHI3L1 and hippocampal atrophy.